Keywords: Roche, BioLamina, R&D agreement, Cell culture systems

Roche and BioLamina collaborate on novel cell culture systems

Article | 06 March 2013

Print This

Swiss drug major Roche (ROG: SIX) has signed an R&D agreement with Sweden’s BioLamina to jointly ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in